GENTICEL : Genticel announces its financial communication calendar for 2015


GENTICEL (Euronext Paris and Brussels: FR0011790542 - GTCL), a French biotechnology company and leading developer of therapeutic vaccines, today announces its financial communication agenda for 2015. This calendar of publication dates is for reference only; it is subject to change if necessary. Each publication will be released after Euronext market closing.

27 January 2015 Business & Cash Position Update 4th Quarter 2014
2 March 2015 2014 Annual Results
28 April 2015 Business & Cash Position Update 1st Quarter 2015
11 June 2015 Annual Shareholders Meeting
28 July 2015 Business & Cash Position Update 2nd Quarter 2015
21 September 2015 2015 Half-Year Results
28 October 2015 Business & Cash Position Update 3rd Quarter 2015

About Genticel
Genticel is a French biopharmaceutical company specialized in the development of therapeutic vaccines aimed at eliminating, at an early stage, the human papillomavirus (HPV) responsible for cervical cancer.

Genticel's most advanced candidate therapeutic vaccine, ProCervix, is currently in a Phase II clinical trial. ProCervix is designed to induce the elimination of cervical cells infected with HPV 16 and/or HPV 18.

Genticel is based in Paris and Toulouse and was awarded the Deloitte Technology Fast 50 "Prix Biotech d'Avenir" (Most promising Biotech) in 2014.

Since April 4, 2014, Genticel shares have been listed on the regulated Euronext markets in Paris and Brussels. For more information, please visit

Benedikt Timmerman
Chief Executive Officer

Brian Stollar

Tel.: +1 (212) 915 2577

Corinne Puissant
Tel.: +33 (0)1 53 67 36 77

Alexandra Prisa
Tel.: +33 (0)1 53 67 36 90

Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués
Communiqué intégral et original au format PDF :

Si le fichier PDF ne s'affiche pas ou pour le télécharger, cliquez ici.

Pour consulter le fichier PDF en intégralité, cliquez ici.

Pour visualiser les documents au format PDF, vous pouvez télécharger gratuitement Acrobat Reader XI.

Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant